Hosted on MSN1mon
Guardian molecule keeps cells on track: New perspectives for the treatment of liver cancerWe tested the guardian molecule in mice that had highly potent cancer mutations in the p53 and Myc genes. PROX1 was able to override the influence of such strong cancer drivers and suppress the ...
Researchers sought to evaluate differences in ctDNA profiles, use of targeted treatments, and overall survival between Black and White patients with metastatic breast cancer.
6d
News-Medical.Net on MSNDecoding programmed cell death in breast cancerThis review highlights the critical role of ubiquitin-specific proteases (USPs) in regulating programmed cell death (PCD) in breast cancer (BC). As the most prevalent malignant tumor among women, BC ...
Figure 8: Regulation of ALDH3A1 and NECTIN4 by p53. Researchers Jessica J. Miciak, Lucy Petrova, Rhythm Sajwan, Aditya Pandya, Mikayla Deckard, Andrew J. Munoz, and Fred Bunz from the Sidney ...
Heat-shock protein 90 (Hsp90) inhibitor downregulates c-Myc expression and upregulates the expression of tumor repressor proteins such as p53 and pRB, inhibiting the G1/S transition and causing G2 ...
Hosted on MSN2mon
Jacobio’s KRAS Inhibitor Glecirasib Shows Promising Trial ResultsIts research pipeline targets six major signaling pathways: KRAS, immune checkpoints, tumor metabolism, P53, RB, and MYC, with the aim of becoming a global leader in drug research and development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results